318 related articles for article (PubMed ID: 38004502)
21. A correlative synopsis of the leukodystrophies.
Morell P
Neuropediatrics; 1984 Sep; 15 Suppl():62-5. PubMed ID: 6546165
[TBL] [Abstract][Full Text] [Related]
22. Gene therapy for metachromatic leukodystrophy.
Rosenberg JB; Kaminsky SM; Aubourg P; Crystal RG; Sondhi D
J Neurosci Res; 2016 Nov; 94(11):1169-79. PubMed ID: 27638601
[TBL] [Abstract][Full Text] [Related]
23. Leber's congenital amaurosis and the role of gene therapy in congenital retinal disorders.
Sharif W; Sharif Z
Int J Ophthalmol; 2017; 10(3):480-484. PubMed ID: 28393043
[TBL] [Abstract][Full Text] [Related]
24. Generation of Human Induced Pluripotent Stem Cell-Derived Bona Fide Neural Stem Cells for Ex Vivo Gene Therapy of Metachromatic Leukodystrophy.
Meneghini V; Frati G; Sala D; De Cicco S; Luciani M; Cavazzin C; Paulis M; Mentzen W; Morena F; Giannelli S; Sanvito F; Villa A; Bulfone A; Broccoli V; Martino S; Gritti A
Stem Cells Transl Med; 2017 Feb; 6(2):352-368. PubMed ID: 28191778
[TBL] [Abstract][Full Text] [Related]
25. Transplant outcomes in leukodystrophies.
Orchard PJ; Tolar J
Semin Hematol; 2010 Jan; 47(1):70-8. PubMed ID: 20109614
[TBL] [Abstract][Full Text] [Related]
26. Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access.
Fumagalli F; Calbi V; Natali Sora MG; Sessa M; Baldoli C; Rancoita PMV; Ciotti F; Sarzana M; Fraschini M; Zambon AA; Acquati S; Redaelli D; Attanasio V; Miglietta S; De Mattia F; Barzaghi F; Ferrua F; Migliavacca M; Tucci F; Gallo V; Del Carro U; Canale S; Spiga I; Lorioli L; Recupero S; Fratini ES; Morena F; Silvani P; Calvi MR; Facchini M; Locatelli S; Corti A; Zancan S; Antonioli G; Farinelli G; Gabaldo M; Garcia-Segovia J; Schwab LC; Downey GF; Filippi M; Cicalese MP; Martino S; Di Serio C; Ciceri F; Bernardo ME; Naldini L; Biffi A; Aiuti A
Lancet; 2022 Jan; 399(10322):372-383. PubMed ID: 35065785
[TBL] [Abstract][Full Text] [Related]
27. Widespread enzymatic correction of CNS tissues by a single intracerebral injection of therapeutic lentiviral vector in leukodystrophy mouse models.
Lattanzi A; Neri M; Maderna C; di Girolamo I; Martino S; Orlacchio A; Amendola M; Naldini L; Gritti A
Hum Mol Genet; 2010 Jun; 19(11):2208-27. PubMed ID: 20203170
[TBL] [Abstract][Full Text] [Related]
28. Hematopoietic stem cell gene therapy in Hurler syndrome, globoid cell leukodystrophy, metachromatic leukodystrophy and X-adrenoleukodystrophy.
Cartier N; Aubourg P
Curr Opin Mol Ther; 2008 Oct; 10(5):471-8. PubMed ID: 18830923
[TBL] [Abstract][Full Text] [Related]
29. Treatment of cerebral adrenoleukodystrophy: allogeneic transplantation and lentiviral gene therapy.
Gupta AO; Raymond G; Pierpont EI; Kemp S; McIvor RS; Rayannavar A; Miller B; Lund TC; Orchard PJ
Expert Opin Biol Ther; 2022 Sep; 22(9):1151-1162. PubMed ID: 36107226
[TBL] [Abstract][Full Text] [Related]
30. Adulthood leukodystrophies.
Köhler W; Curiel J; Vanderver A
Nat Rev Neurol; 2018 Feb; 14(2):94-105. PubMed ID: 29302065
[TBL] [Abstract][Full Text] [Related]
31. Hematopoietic stem cell transplantation and hematopoietic stem cell gene therapy in X-linked adrenoleukodystrophy.
Cartier N; Aubourg P
Brain Pathol; 2010 Jul; 20(4):857-62. PubMed ID: 20626747
[TBL] [Abstract][Full Text] [Related]
32. Leber's congenital amaurosis with Duchenne's muscular dystrophy.
Hazariwala K; Brownstein S; Polomeno R; Little JM; Labuda D
Can J Ophthalmol; 1990 Jun; 25(4):202-7. PubMed ID: 1972344
[TBL] [Abstract][Full Text] [Related]
33. Epilepsy in children with leukodystrophies.
Zhang J; Ban T; Zhou L; Ji H; Yan H; Shi Z; Cao B; Jiang Y; Wang J; Wu Y
J Neurol; 2020 Sep; 267(9):2612-2618. PubMed ID: 32388833
[TBL] [Abstract][Full Text] [Related]
34. Novel and known morbidities of leukodystrophies identified using a phenome-wide association study.
Bonkowsky JL; Wilkes J; Ying J; Wei WQ
Neurol Clin Pract; 2020 Oct; 10(5):406-414. PubMed ID: 33299668
[TBL] [Abstract][Full Text] [Related]
35. Developing therapeutic approaches for metachromatic leukodystrophy.
Patil SA; Maegawa GH
Drug Des Devel Ther; 2013; 7():729-45. PubMed ID: 23966770
[TBL] [Abstract][Full Text] [Related]
36. Leukodystrophies with late disease onset: an update.
Köhler W
Curr Opin Neurol; 2010 Jun; 23(3):234-41. PubMed ID: 20216214
[TBL] [Abstract][Full Text] [Related]
37. Opening New Horizons in the Treatment of Childhood Onset Leukodystrophies.
Schiller S; Henneke M; Gärtner J
Neuropediatrics; 2019 Aug; 50(4):211-218. PubMed ID: 31113002
[TBL] [Abstract][Full Text] [Related]
38. Genetic testing of leukodystrophies unraveling extensive heterogeneity in a large cohort and report of five common diseases and 38 novel variants.
Mahdieh N; Soveizi M; Tavasoli AR; Rabbani A; Ashrafi MR; Kohlschütter A; Rabbani B
Sci Rep; 2021 Feb; 11(1):3231. PubMed ID: 33547378
[TBL] [Abstract][Full Text] [Related]
39. Hereditary Retinal Dystrophy.
Hohman TC
Handb Exp Pharmacol; 2017; 242():337-367. PubMed ID: 28035529
[TBL] [Abstract][Full Text] [Related]
40. Gene Therapy in Fanconi Anemia: A Matter of Time, Safety and Gene Transfer Tool Efficiency.
Verhoeyen E; Roman-Rodriguez FJ; Cosset FL; Levy C; Rio P
Curr Gene Ther; 2017; 16(5):297-308. PubMed ID: 28067165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
